Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients
Open Access
- 1 May 2013
- journal article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 8 (1) , 71
Abstract
Background: Small breast epithelial mucin (SBEM) has been implicated in tumor genesis and micrometastasis in breast cancer. Triple-negative breast cancer (TNBC) was characterized by high incidence in young women,early relapse and a very poor prognosis. The aim of this study was to evaluate the association of SBEM expression in tissues of TNBC with disease-free survival (DFS) and overall survival (OS). Methods: SBEM protein expression was detected in 87 available formalin-fixed paraffin-embedded (FFPE) tissue specimens from TNBC patients by means of immunohistochemistry (IHC). We analyzed the correlation between the SBEM protein expression and DFS and OS during a 5 year follow-up period, respectively. And a SBEM cut-off value of prognosis was established associated with DFS and OS. SBEM was analyzed against other risk factors in multivariate analysis. Results: SBEM 3+ score was cut-off value of prognosis and significantly correlated with DFS (p = 0.000) and OS (p = 0.001) in TNBC patients. There was a marked associations (p p = 0.008 for DFS and HR = 4.185 with p = 0.004 for OS). Conclusions: SBEM is an independent risk predictor and may offer utility as a prognostic marker in TNBC patients. Virtual Slides: http://www.diagnosticpathology.diagnomx.eu/vs/1624613061936917Keywords
This publication has 27 references indexed in Scilit:
- An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomasDiagnostic Pathology, 2013
- The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patientsDiagnostic Pathology, 2012
- Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from MoroccoDiagnostic Pathology, 2012
- Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysisDiagnostic Pathology, 2012
- Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical studyDiagnostic Pathology, 2012
- Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylationMolecular Cancer, 2010
- Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancerMolecular Cancer, 2010
- Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancersHistopathology, 2008
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001